COVID-19 and family planning service delivery: Findings from a survey of U.S. physicians
- PMID: 34081938
- PMCID: PMC8316381
- DOI: 10.1016/j.ypmed.2021.106664
COVID-19 and family planning service delivery: Findings from a survey of U.S. physicians
Abstract
Equitable access to contraception is critical for reproductive autonomy. Using cross-sectional data from the DocStyles survey administered September-October 2020 (68% response rate), we compared changes in family planning-related clinical services and healthcare delivery strategies before and during the COVID-19 pandemic and assessed service provision issues among 1063 U.S. physicians whose practice provided family planning services just before the pandemic. About one-fifth of those whose practices provided the following services or strategies just before the pandemic discontinued these services during the pandemic: long-acting reversible contraception (LARC) placement (16%); LARC removal (17%); providing or prescribing emergency contraceptive pills (ECPs) in advance (18%); and reminding patients about contraception injections or LARC removal or replacement (20%). Many practices not providing the following services or strategies just before the pandemic initiated these services during the pandemic: telehealth for contraception initiation (43%); telehealth for contraception continuation (48%); and renewing contraception prescriptions without requiring an office visit (36%). While a smaller proportion of physicians reported service provision issues in the month before survey completion than at any point during the pandemic, about one-third still reported fewer adult females seeking care (37%) and technical challenges with telehealth (32%). Discontinuation of key family planning services during the COVID-19 pandemic may limit contraception access and impede reproductive autonomy. Implementing healthcare service delivery strategies that reduce the need for in-person visits (e.g., telehealth for contraception, providing or prescribing ECPs in advance) may decrease disruptions in care. Resources exist for public health and clinical efforts to ensure contraception access during the pandemic.
Keywords: COVID-19; Contraception; Family planning; Reproductive health.
Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
COVID-19 and Sexual and Reproductive Health Care: Findings From Primary Care Providers Who Serve Adolescents.J Adolesc Health. 2021 Sep;69(3):375-382. doi: 10.1016/j.jadohealth.2021.06.002. Epub 2021 Jul 21. J Adolesc Health. 2021. PMID: 34301467 Free PMC article.
-
Is the COVID-19 Pandemic Continuing to Impact Sexual and Reproductive Health Services for Adolescents? Findings From a 2021 Survey of US Physicians.J Adolesc Health. 2023 May;72(5):696-702. doi: 10.1016/j.jadohealth.2022.12.011. Epub 2023 Feb 10. J Adolesc Health. 2023. PMID: 36775748 Free PMC article.
-
The impact of the COVID-19 pandemic on postpartum contraception planning.Am J Obstet Gynecol MFM. 2021 Sep;3(5):100412. doi: 10.1016/j.ajogmf.2021.100412. Epub 2021 May 28. Am J Obstet Gynecol MFM. 2021. PMID: 34058421 Free PMC article.
-
Barriers to accessing post-pregnancy contraception in Brazil: The impact of COVID-19.Best Pract Res Clin Obstet Gynaecol. 2024 Jun;94:102482. doi: 10.1016/j.bpobgyn.2024.102482. Epub 2024 Feb 23. Best Pract Res Clin Obstet Gynaecol. 2024. PMID: 38428278 Review.
-
Canadian Contraception Consensus (Part 1 of 4).J Obstet Gynaecol Can. 2015 Oct;37(10):936-42. doi: 10.1016/s1701-2163(16)30033-0. J Obstet Gynaecol Can. 2015. PMID: 26606712 English, French.
Cited by
-
Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic-United States, January 2019-September 2020.Womens Health Issues. 2024 Mar-Apr;34(2):186-196. doi: 10.1016/j.whi.2023.10.004. Epub 2023 Dec 7. Womens Health Issues. 2024. PMID: 38065719 Free PMC article.
-
Unwanted sexual activity among United States women early in the COVID-19 pandemic.Am J Obstet Gynecol. 2023 Feb;228(2):209.e1-209.e16. doi: 10.1016/j.ajog.2022.09.048. Epub 2022 Oct 12. Am J Obstet Gynecol. 2023. PMID: 36241078 Free PMC article.
-
Assessing differences in contraceptive provision through telemedicine among reproductive health providers during the COVID-19 pandemic in the United States.Reprod Health. 2022 Apr 22;19(1):99. doi: 10.1186/s12978-022-01388-9. Reprod Health. 2022. PMID: 35459218 Free PMC article.
-
Telehealth for Women's Preventive Services for Reproductive Health and Intimate Partner Violence: a Comparative Effectiveness Review.J Gen Intern Med. 2023 May;38(7):1735-1743. doi: 10.1007/s11606-023-08033-6. Epub 2023 Jan 17. J Gen Intern Med. 2023. PMID: 36650334 Free PMC article.
-
Disruption and recovery of family planning, contraception and other sexual and reproductive health services in Brazil with COVID-19 pandemic: a mixed methods approach.Reprod Health. 2025 Aug 8;22(Suppl 3):143. doi: 10.1186/s12978-025-02088-w. Reprod Health. 2025. PMID: 40781681 Free PMC article.
References
-
- Ali M., Bahamondes L., Bent Landoulsi S. Extended effectiveness of the etonogestrel-releasing contraceptive implant and the 20 μg levonorgestrel-releasing intrauterine system for 2 years beyond U.S. Food and Drug Administration product labeling. Glob Health Sci Pract. 2017;5(4):534–539. - PMC - PubMed
-
- Centers for Disease Control and Prevention (CDC) Healthcare Facilities: Managing Operations During the COVID-19 Pandemic. 2020. https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-hcf.html [cited 2020 December 8]; Available from:
-
- Converge Partners in Action. Provision of Person-Centered Reproductive Health Care via Telemedicine 2020. https://convergems.org/wp2019/wp-content/uploads/2020/08/PCRH-and-Teleme... [cited 2020 December 8]; Available from:
-
- Cox C., Amin K. Kaiser Family Foundation and the Peterson Center on Healthcare; 2020. How have health spending and utilization changed during the coronavirus pandemic?
-
- Curtis K.M., Tepper N.K., Jatlaoui T.C., Berry-Bibee E., Horton L.G., Zapata L.B., et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR Recomm. Rep. 2016;65(3):1–103. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical